Extinction Pharmaceuticals
Williamsburg, Virginia
CEO: Jason McDevitt
Company Status: Private
Investment Status: Current
Fund: GAP BioLife Fund
Drug discovery company with a proprietary and revoluntionary therapeuitc approach for treating anxiety disorders and other afflictions that can benefit from traditional talk therapy treatments.